250 related articles for article (PubMed ID: 28882604)
1. [Contribution of temozolomide chemotherapy for intramedullary grade II spinal cord astrocytomas in adults: Our experience].
Chaskis E; Minichini V; Luce S; Devriendt D; Goldman S; De Witte O; Sadeghi N; Lefranc F
Neurochirurgie; 2017 Sep; 63(4):297-301. PubMed ID: 28882604
[TBL] [Abstract][Full Text] [Related]
2. Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.
Sipos L; Vitanovics D; Afra D
Ideggyogy Sz; 2004 Nov; 57(11-12):394-9. PubMed ID: 15662767
[TBL] [Abstract][Full Text] [Related]
3. Temozolomide for recurrent low-grade spinal cord gliomas in adults.
Chamberlain MC
Cancer; 2008 Sep; 113(5):1019-24. PubMed ID: 18615600
[TBL] [Abstract][Full Text] [Related]
4. Temozolomide or bevacizumab for spinal cord high-grade gliomas.
Kaley TJ; Mondesire-Crump I; Gavrilovic IT
J Neurooncol; 2012 Sep; 109(2):385-9. PubMed ID: 22678696
[TBL] [Abstract][Full Text] [Related]
5. Expression of O6-methylguanine-deoxyribose nucleic acid methyltransferase and temozolomide response in a patient with a malignant spinal cord astrocytoma. Case report.
Rovin RA; Winn R
J Neurosurg Spine; 2007 May; 6(5):447-50. PubMed ID: 17542512
[TBL] [Abstract][Full Text] [Related]
6. Temozolomide in pediatric low-grade glioma.
Khaw SL; Coleman LT; Downie PA; Heath JA; Ashley DM
Pediatr Blood Cancer; 2007 Nov; 49(6):808-11. PubMed ID: 17588234
[TBL] [Abstract][Full Text] [Related]
7. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL; Weber WA; Franz M; Stärk S; Piert M; Thamm R; Gumprecht H; Schwaiger M; Molls M; Nieder C
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):511-9. PubMed ID: 16168843
[TBL] [Abstract][Full Text] [Related]
8. Role of temozolomide in spinal cord low grade astrocytomas: results in two paediatric patients.
Chamoun RB; Alaraj AM; Al Kutoubi AO; Abboud MR; Haddad GF
Acta Neurochir (Wien); 2006 Feb; 148(2):175-9; discussion 180. PubMed ID: 16374565
[TBL] [Abstract][Full Text] [Related]
9. Intramedullary low grade astrocytoma and ependymoma. Surgical results and predicting factors for clinical outcome.
Eroes CA; Zausinger S; Kreth FW; Goldbrunner R; Tonn JC
Acta Neurochir (Wien); 2010 Apr; 152(4):611-8. PubMed ID: 20119838
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced spinal cord anaplastic astrocytoma subsequent to radiotherapy for testicular seminoma.
Kawanabe Y; Sawada M; Yukawa H; Ueda S; Sasaki N; Koizumi T; Kihara S; Hoshimaru M
Neurol Med Chir (Tokyo); 2012; 52(9):675-8. PubMed ID: 23006885
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas.
Brada M; Viviers L; Abson C; Hines F; Britton J; Ashley S; Sardell S; Traish D; Gonsalves A; Wilkins P; Westbury C
Ann Oncol; 2003 Dec; 14(12):1715-21. PubMed ID: 14630674
[TBL] [Abstract][Full Text] [Related]
12. Independent association of extent of resection with survival in patients with malignant brain astrocytoma.
McGirt MJ; Chaichana KL; Gathinji M; Attenello FJ; Than K; Olivi A; Weingart JD; Brem H; Quiñones-Hinojosa AR
J Neurosurg; 2009 Jan; 110(1):156-62. PubMed ID: 18847342
[TBL] [Abstract][Full Text] [Related]
13. Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: three case studies and a review of the literature.
Hassall TE; Mitchell AE; Ashley DM
Neuro Oncol; 2001 Oct; 3(4):251-7. PubMed ID: 11584895
[No Abstract] [Full Text] [Related]
14. Temozolomide for malignant primary spinal cord glioma: an experience of six cases and a literature review.
Kim WH; Yoon SH; Kim CY; Kim KJ; Lee MM; Choe G; Kim IA; Kim JH; Kim YJ; Kim HJ
J Neurooncol; 2011 Jan; 101(2):247-54. PubMed ID: 20526650
[TBL] [Abstract][Full Text] [Related]
15. Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.
Yung WK; Prados MD; Yaya-Tur R; Rosenfeld SS; Brada M; Friedman HS; Albright R; Olson J; Chang SM; O'Neill AM; Friedman AH; Bruner J; Yue N; Dugan M; Zaknoen S; Levin VA
J Clin Oncol; 1999 Sep; 17(9):2762-71. PubMed ID: 10561351
[TBL] [Abstract][Full Text] [Related]
16. Spinal Cord Astrocytoma with Isocitrate Dehydrogenase 1 Gene Mutation.
Takai K; Tanaka S; Sota T; Mukasa A; Komori T; Taniguchi M
World Neurosurg; 2017 Dec; 108():991.e13-991.e16. PubMed ID: 28866063
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of childhood intramedullary spinal cord astrocytomas with irinotecan and cisplatin.
Mora J; Cruz O; Gala S; Navarro R
Neuro Oncol; 2007 Jan; 9(1):39-46. PubMed ID: 17108066
[TBL] [Abstract][Full Text] [Related]
18. A first feasibility study of temozolomide for Japanese patients with recurrent anaplastic astrocytoma and glioblastoma multiforme.
Aoki T; Mizutani T; Ishikawa M; Sugiyama K; Hashimoto N
Int J Clin Oncol; 2003 Oct; 8(5):301-4. PubMed ID: 14586755
[TBL] [Abstract][Full Text] [Related]
19. [Favourable result for temozolomide in recurrent high-grade glioma].
Taal W; van der Rijt CD; Sillevis Smitt PA; Kros JM; van Heuvel I; Enting RH; van den Bent MJ
Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1393-9. PubMed ID: 15997692
[TBL] [Abstract][Full Text] [Related]
20. High-grade glioma in children and adolescents: a single-center experience.
Yazici G; Zorlu F; Cengiz M; Ozyigit G; Eren G; Yüce D; Varan A; Akyuz C; Akalan N; Gurkaynak M
Childs Nerv Syst; 2016 Feb; 32(2):291-7. PubMed ID: 26679932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
